Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP3 | P15309 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.46 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.46 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.46 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.46 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | CASR | P41180 | 1/20 | 0.45 |
| ▸ | ALPL | P05186 | 1/20 | 0.45 |
| ▸ | ALPI | P09923 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | ALPG | P10696 | 1/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.44 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10775144 | 0.96 | ACP3 (0.52) | ACP3MEN1KMT2ACACNA1GCACNA2D1 | |
| SCHEMBL14830681 | 0.92 | ACP3 (0.46) | ACP3MEN1KMT2ACACNA1GCACNA2D1 | |
| SCHEMBL11552637 | 0.87 | HTR2A (0.44) | ACP3LMNA | |
| SCHEMBL4058257 | 0.83 | IDO1 (0.50) | MEN1KMT2ACACNA1GCACNA2D1CACNA1B | |
| SCHEMBL193835 | 0.82 | HTR2A (0.52) | LMNA | |
| SCHEMBL8324166 | 0.82 | ACP3 (0.47) | ACP3MEN1KMT2ACACNA1GCACNA2D1 | |
| SCHEMBL17071892 | 0.82 | ACP3 (0.47) | ACP3MEN1KMT2ACACNA1GCACNA2D1 | |
| SCHEMBL3415393 | 0.82 | HTR2A (0.64) | ACP3MEN1KMT2AIDO1TDO2 | |
| SCHEMBL8869652 | 0.81 | MEN1 (0.56) | ACP3MEN1KMT2ACACNA1GCACNA2D1 | |
| SCHEMBL8674097 | 0.81 | MEN1 (0.49) | ACP3MEN1KMT2ACACNA1GCACNA2D1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3528776-B1 | REDUCED-ETHANOL MOUTH RINSE FORMULATIONS | KENVUE BRANDS LLC (US) | 2025-11-26 | — | — | EP | disclosed |
| US-11857653-B2 | Method of providing an oral care benefit using a poorly-soluble calcium compound and fluoride | JOHNSON & JOHNSON CONSUMER INC. (US) | 2024-01-02 | — | — | US | disclosed |
| US-11648186-B2 | Coated particles and their uses | JOHNSON & JOHNSON CONSUMER INC. (US) | 2023-05-16 | — | — | US | disclosed |
| US-20220226205-A1 | Coated Particles and Their Uses | KENVUE BRANDS LLC | 2022-07-21 | — | — | US | disclosed |
| US-11351103-B2 | Method of providing oral care benefits | JOHNSON & JOHNSON CONSUMER INC. (US) | 2022-06-07 | — | — | US | disclosed |
| US-11291613-B2 | Coated particles and their uses | JOHNSON & JOHNSON CONSUMER INC. (US) | 2022-04-05 | — | — | US | disclosed |
| EP-3897511-A1 | METHOD OF PROVIDING AN ORAL CARE BENEFIT USING A POORLY-SOLUBLE CALCIUM COMPOUND AND FLUORIDE | Johnson & Johnson Consumer Inc. (US) | 2021-10-27 | — | — | EP | disclosed |
| EP-3270873-B1 | CALCIUM-BASED DENTIFRICES FOR ENHANCED UPTAKE OF ACTIVE INGREDIENTS | COLGATE PALMOLIVE CO (US) | 2020-11-25 | — | — | EP | disclosed |
| WO-2020128680-A1 | METHOD OF PROVIDING AN ORAL CARE BENEFIT USING A POORLY-SOLUBLE CALCIUM COMPOUND AND FLUORIDE | JOHNSON & JOHNSON CONSUMER INC. (US) | 2020-06-25 | — | — | WO | disclosed |
| US-20200188245-A1 | Method of Providing an Oral Care Benefit using a Poorly-soluble Calcium Compound and Fluoride | KENVUE BRANDS LLC | 2020-06-18 | — | — | US | disclosed |
| US-5776435-A | DENTIFRICES | COLGATE-PALMOLIVE COMPANY (US) | 1998-07-07 | — | — | US | disclosed |
| EP-0565401-B1 | Continuous process for making a non-newtonian paste or cream like material | COLGATE PALMOLIVE CO (US) | 1997-06-18 | — | — | EP | disclosed |
| US-5320832-A | Low viscosity slurry; cosmetics or dentifrice | COLGATE PALMOLIVE (US) | 1994-06-14 | — | — | US | disclosed |
| US-5288480-A | Antiplaque antibacterial oral composition | COLGATE-PALMOLIVE CO. (US) | 1994-02-22 | — | — | US | disclosed |
| EP-0565401-A1 | Continuous process for making a non-newtonian paste or cream like material | Colgate-Palmolive Company (US) | 1993-10-13 | — | — | EP | disclosed |
| US-5236696-A | High shear mixing of aqueous and non aqueous, low viscosity, homogeneous slurries; transforming to high viscosity in maturing tank with no agitation | COLGATE-PALMOLIVE COMPANY (US) | 1993-08-17 | — | — | US | disclosed |
| US-5178851-A | Dentifrices treatment with triclosan and carriers | COLGATE-PALMOLIVE COMPANY (US) | 1993-01-12 | — | — | US | disclosed |
| US-5037635-A | Antibacterial antiplaque oral composition | COLATE-PALMOLIVE COMPANY (US) | 1991-08-06 | — | — | US | disclosed |
| US-5032386-A | Dentistry | COLGATE-PALMOLIVE COMPANY (US) | 1991-07-16 | — | — | US | disclosed |
| US-4894220-A | WATER AND ALCOHOL SOLVENTS, GLYCOL DERIVATIVES AND ESTERS SOLUTIONS | COLGATE-PALMOLIVE COMPANY (US) | 1990-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11291613-B2 | Coated particles and their uses | CD63, EPCAM, CD44 | ACP3 398/4885MEN1 3074/4885KMT2A 2405/4885 |
| US-11648186-B2 | Coated particles and their uses | CD63, EPCAM, CD44 | ACP3 398/4885MEN1 3074/4885KMT2A 2405/4885 |
| US-20220226205-A1 | Coated Particles and Their Uses | CD63, EPCAM, CD44 | ACP3 398/4885MEN1 3074/4885KMT2A 2405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.